Company profile
Integra LifeSciences Holdings Corporation
NASDAQ: IART · Healthcare · Medical - Devices
#122 of 1,418 Healthcare companies by revenue45th-percentile growth
EA Score
67BFH 61DQ 73GM 61SS 89
v0.1 · 65/100 weight · provisional
↑ growth stability, filing timeliness · ↓ balance-sheet leverage, 3-yr revenue growth
Methodology →Revenue TTM
$1.6B
Rev growth YoY (TTM)
+1.2%
Net income (FY)
-$516.5M
Employees
4,427
as of 2026-08-09
Market cap
$1.3B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.6B$1.6B2025
Net income-$516.5M-$516.5M2025
Operating income-$493.4M-$493.4M2025
Total assets$3.6B$3.6B2025
Liabilities$2.6B$2.6B2025
Equity$1.0B$1.0B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Codman Specialty Surgical73%
Tissue Technologies27%
By geography
UNITED STATES74%
Asia Pacific12%
Europe10%
Rest Of The World5%
The read
What is Integra LifeSciences Holdings Corporation’s revenue?
Integra LifeSciences Holdings Corporation booked $1.6B in FY2025 revenue, growing 1.5% year over year — about the middle of the pack among Healthcare companies we track, at a -31.6% net margin.
Peers · Healthcare
Healthcare Services Group, Inc.87AAmerican Oncology Network, Inc.——PTC Therapeutics, Inc.72BLantheus Holdings, Inc.79B+Merit Medical Systems, Inc.83B+National HealthCare Corporation78B+Neighbors
Mercer →Key facts
CEOStuart Essig
SectorHealthcare
IndustryMedical - Devices
HeadquartersPrinceton, NJ
ExchangeNASDAQ: IART
Employees4,427
IPO date1995-08-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.